The aim of this study was to fortify the clinical importance and representation of toxigenic and non-toxigenic Clostridium difficile isolated from stool samples of hospitalized patients. This survey included 80 hospitalized patients with diarrhea and positive findings of Clostridium difficile in stool samples, and 100 hospitalized patients with formed stool as a control group.
INTRODUCTION
Clostridium (C.) difficile is an anaerobic, gram -positive, spore forming bacteria, is commonly present in soil and add intestinal tract of animals, healthy children and adults.
Intrahospital infections caused by C. difficile are commonly related to contaminated surfaces of facilities or by the unclean hands of medical staff (17) .
By the opinion of numerous medical researchers (3, 4, 7) there are toxigenic and non-toxigenic C. difficile strains. (1, 3, 6) .
Results of many studies, conducted over the past twenty years, have shown that toxigenic strains were present in about 60 to 90% of patients with diarrhea and C. difficile (4, 17, 24) .
In microbiological laboratories across Europe, among toxigenic strains, the most frequently cultivated A+B+ strain (up to 97%) (21) . The prevalence of C. difficile A-/B+ strain is higher in other parts of the World, such as Japan (39%), Korea (43%), and Israel (56%). These strains are most dominant in Argentina (97.9%), regarding to total number of toxigenic isolates (6, 11, 14, 22, 23 According to available data from referent literature, until the present day, the investigation of CDAD has not been conducted in Serbia, and this is the first research considering of this health problem.
The aim of the study is determination of clinical importance and representation of toxigenic and non-toxigenic Clostridium difficile presence in stool samples of hospitalized patients.
MATERIALS AND METHODS

Research was performed at the Institute of Public Health
Nis -Serbia, Center for Microbiology, during the period from hospitalized patients with diarrhea. The selection of patients was based on following criteria:
• Presence of at least three unformed or liquid stools during 24h for at least 2 days.
• Hospitalization, at least 48h before the appearance of unformed or liquid stool.
• Cultivation of C. difficile (toxigenic and non-toxigenic strains) from examined stool samples. (Table 2) . One hundred stool samples of hospitalized patients from control group (57% male, and 43% female; age ranged from 14 to 84 years), were also examined. Toxigenic C. difficile was cultivated from the stool samples of two patients (2%).
Presence of non-toxigenic C. difficile was confirmed in samples of five patients (5%). During this research, we were specifically focused on clinical parameters for the following subgroup of patients:
• Three patients with normal intestinal microbiota isolates and non-toxigenic C. difficile, where diarrhea spontaneously stopped after they finished antibiotic therapy previously prescribed (subgroup 1).
• Two patients with normal intestinal microbiota isolates and non-toxigenic C. difficile, with metronidazole therapy for diarrhea (subgroup 2).
• Five patients with diarrhea and non-toxigenic C. (Table 3) . 
